Franklin Biolabs Launches to Transform Genetic Medicines
Introducing Franklin Biolabs, an innovative contract research organization (CRO) that is making strides in the genetic medicines sector. Founded by the renowned gene therapy pioneer, Dr. James Wilson, this new company brings together a highly skilled team of over 130 experts dedicated to advancing the field of genetic medicine. With a commitment to providing comprehensive services, from discovery to development and distribution, Franklin Biolabs is poised to become a leader in the global genetic medicines industry.
Comprehensive Services to Advance Gene Therapy
The array of services offered by Franklin Biolabs is diverse and reflects the industry's growing demands. The company specializes in immunology, vector production and analytics, and bioinformatics, as well as next-generation sequencing and nonclinical pharmacology/toxicology studies. This multifaceted approach enables Franklin Biolabs to cater to various aspects of genetic medicine, ensuring that it can provide essential support for researchers and companies focusing on gene therapy innovation.
Inspired by Innovation
The name Franklin Biolabs pays homage to the brilliant American scientist and inventor, Ben Franklin. This tribute reflects the company’s ethos of innovation and progress, echoing the spirit of advancement that Franklin embodied. The company is headquartered in a vibrant city known for its rich history in science and technology. By conducting research across continents, Franklin Biolabs is prepared to make a global impact.
Strategic Investment for Growth
Backed by Savanne Life Sciences, Franklin Biolabs is positioned strongly to develop genetic medicines aimed at treating various severe disorders. This partnership signifies a shared vision for reshaping the landscape of the genetic medicines industry through strategic investment and collaboration. Dr. Wilson, the Chairperson of Franklin Biolabs, expresses gratitude for Savanne's support and highlights a mutual goal of connecting groundbreaking research to transformative therapies for patients in need.
Collaboration with Savanne Life Sciences
The collaboration with Savanne Life Sciences brings valuable experience and resources to Franklin Biolabs. Savanne is well-versed in the biotechnology sector and has established partnerships with top-tier companies and research institutions. This strategic alliance aims to leverage an expansive network of knowledge and resources, enabling Franklin Biolabs to accelerate the commercialization of genetic medicines and cater to the needs of patients worldwide.
A Focus on Disruptive Solutions
With an unwavering focus on delivering disruptive solutions, Franklin Biolabs is dedicated to pushing the boundaries of gene therapy. The company aims to bridge the gap between innovative scientific discoveries and clinical application, enhancing the capabilities of researchers and biotechs globally. This commitment to excellence positions Franklin Biolabs as a vital partner in the journey towards bringing life-saving therapies to the market.
About Franklin Biolabs
As a forward-thinking contract research organization, Franklin Biolabs is revolutionizing the genetic medicines industry. By offering a complete suite of services from discovery to clinical vector manufacturing, the company stands ready to alleviate severe health challenges faced by many patients. Led by industry leader Dr. Jim Wilson, who also serves as President and CEO of GEMMABio, the company is dedicated to transforming scientific innovations into clinically available therapies.
Franklin Biolabs is committed to bringing cutting-edge treatments to life, ensuring that patients benefit from the latest advancements in genetic medicine. The company’s vision is not only to innovate but also to humanize the science behind genetic therapies, bringing hope to those grappling with dire medical conditions.
Frequently Asked Questions
What is Franklin Biolabs focused on?
Franklin Biolabs specializes in providing contract research services for the genetic medicines industry, focusing on gene therapy innovations.
Who founded Franklin Biolabs?
The company was founded by gene therapy pioneer Dr. James Wilson, an expert dedicated to advancing the field of genetic medicine.
What kind of services does the company offer?
They provide diverse services including immunology, vector production, bioinformatics, sequencing, and nonclinical studies.
How is Franklin Biolabs supported financially?
Franklin Biolabs is backed by Savanne Life Sciences, which provides strategic investment and resources to help the company grow.
What is the vision of Franklin Biolabs?
The vision is to connect innovative research with transformative therapies, improving the lives of patients with severe and disabling conditions.
